Sensory-motor axonal multineuropathy during etanercept therapy for rheumatoid arthritis
De Stefano, R.; Frati, E.; Volpi, N.; Galeazzi, M.
Clinical and Experimental Rheumatology 27(2): 381
2009
ISSN/ISBN: 0392-856X PMID: 19473586 Document Number: 629948
Document emailed within 1 workday
Related Documents
Ilić, T.; Milić, B.; Ćelić, D.; Vučković, B.; Mitić, I. 2013: Etanercept therapy in rheumatoid arthritis: efficacy and safety Srpski Arhiv Za Celokupno Lekarstvo 141(7-8): 495-502D'Amore, M.; Minenna, G.; Nigro, A.; Favia, I.; D'Amore, S. 2005: Etanercept in the treatment of rheumatoid arthritis. A case report Recenti Progressi in Medicina 96(4): 187-189
Hu, S.; Cohen, D.; Murphy, G.; Mody, E.; Qureshi, A.A. 2008: Interstitial granulomatous dermatitis in a patient with rheumatoid arthritis on etanercept Cutis 81(4): 336-338
Kietz, D.A.; Pepmueller, P.H.; Moore, T.L. 2001: Clinical response to etanercept in polyarticular course juvenile rheumatoid arthritis Journal of Rheumatology 28(2): 360-362
Bal, A.; Gurcay, E.; Aydog, E.; Unlu, E.; Umay, E.; Cakci, A. 2008: Neuralgic amyotrophy due to rheumatoid arthritis or etanercept: causal association or coincidence? Indian Journal of Medical Research 127(1): 89-90
Bathon, J.M.; Fleischmann, R.M.; Van der Heijde, Désirée.; Tesser, J.R.; Peloso, P.M.; Chon, Y.; White, B. 2006: Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis Journal of Rheumatology 33(2): 234-243
Wooten, M.D.; Reddy, G.V.; Johnson, R.D. 2000: Atrial fibrillation occurring in a patient taking etanercept plus methotrexate for rheumatoid arthritis Delaware Medical Journal 72(12): 517-519
Cancelliere, N.; Barranco, P.; Vidaurrázaga, C.; Benito, D.-M.; Quirce, S. 2011: Subacute prurigo and eosinophilia in a patient with rheumatoid arthritis receiving infliximab and etanercept Journal of Investigational Allergology and Clinical Immunology 21(3): 248-249
Johnsen, A.K.; Schiff, M.H.; Mease, P.J.; Moreland, L.W.; Maier, A.L.; Coblyn, J.S.; Helfgott, S.M.; Leff, J.A.; Weinblatt, M.E. 2006: Comparison of 2 doses of etanercept (50 vs 100 mg) in active rheumatoid arthritis: a randomized double blind study Journal of Rheumatology 33(4): 659-664
Bout-Tabaku, S.; Rivas-Chacon, R.; Restrepo, R. 2007: Systemic lupus erythematosus in a patient treated with etanercept for polyarticular juvenile rheumatoid arthritis Journal of Rheumatology 34(12): 2503-2504
Laganà, B.; Picchianti Diamanti, A.; Germano, V.; Argento, G.; Ferlito, C.; D Amelio, R. 2008: Two-year follow-up in an early rheumatoid arthritis patient treated with etanercept: radiological involvement despite clinical remission Journal of Biological Regulators and Homeostatic Agents 22(4): 271-273
Yang, M.; Galebach, P.J.; Signorovitch, J.E.; Garg, V. 2017: Effectiveness and healthcare costs among stabilised rheumatoid arthritis patients with dose reduction of adalimumab or etanercept in real world Clinical and Experimental Rheumatology 35(5): 791-798
Detert, J.; Dziurla, R.é; Hoff, P.; Gaber, T.; Klaus, P.; Bastian, H.; Braun, T.; Schellmann, S.; Penzel, T.; Fietze, I.; Loeschmann, P.-A.; Jaehnig, P.; Straub, R.H.; Burmester, G.R.; Buttgereit, F. 2016: Effects of treatment with etanercept versus methotrexate on sleep quality, fatigue and selected immune parameters in patients with active rheumatoid arthritis Clinical and Experimental Rheumatology 34(5): 848-856
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Wasiak, A.; Gusta, A. 1985: Causes of the limitation of motor functions in patients with rheumatoid arthritis after alloplasty of the hip joint Chirurgia Narzadow Ruchu i Ortopedia Polska 50(5): 399-402
Kimball, A.B.; Jackson, J.M.; Sobell, J.M.; Boh, E.E.; Grekin, S.; Pharmd, E.B.Y.; Woolley, J.M.; Xia, H.A.; Chiou, C.-F.; Stevens, S.R. 2007: Reductions in healthcare resource utilization in psoriatic arthritis patients receiving etanercept therapy: results from the educate trial Journal of Drugs in Dermatology: Jdd 6(3): 299-306
Mano, Y.; Nakamuro, T.; Ikoma, K.; Takayanagi, T.; Mayer, R.F. 1993: A clinicophysiologic study of central and peripheral motor conduction in hereditary demyelinating motor and sensory neuropathy Electromyography and Clinical Neurophysiology 33(2): 101-107
De Filippis, L.; Caliri, A.; Anghelone, S.; Scibilia, G.; Lo Gullo, R.; Bagnato, G. 2006: Improving outcomes in tumour necrosis factor a treatment: comparison of the efficacy of the tumour necrosis factor a blocking agents etanercept and infliximab in patients with active rheumatoid arthritis Panminerva Medica 48(2): 129-135
Tse, S.M.L.; Laxer, R.M.; Babyn, P.S.; Doria, A.S. 2006: Radiologic Improvement of juvenile idiopathic arthritis-enthesitis-related arthritis following anti-tumor necrosis factor-alpha blockade with etanercept Journal of Rheumatology 33(6): 1186-1188
Marhoffer, W.; Schatz, H.; Stracke, H.; Ullmann, J.; Schmidt, K.; Federlin, K. 1991: Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis Journal of Rheumatology 18(8): 1158-1162